Index S&P 500
P/E 42.17
EPS (ttm) 5.90
Insider Own 8.82%
Shs Outstand 739.20M
Perf Week 0.87%
Market Cap 184.25B
Forward P/E 28.72
EPS next Y 8.66
Insider Trans -0.16%
Shs Float 675.37M
Perf Month 1.85%
Income 4.40B
PEG 5.61
EPS next Q 1.59
Inst Own 81.75%
Short Float 0.92%
Perf Quarter 0.23%
Sales 26.23B
P/S 7.02
EPS this Y 0.26%
Inst Trans -0.21%
Short Ratio 2.40
Perf Half Y 25.72%
Book/sh 72.16
P/B 3.45
EPS next Y 13.99%
ROA 5.28%
Short Interest 6.20M
Perf Year 15.76%
Cash/sh 9.49
P/C 26.21
EPS next 5Y 7.52%
ROE 8.47%
52W Range 182.09 - 259.00
Perf YTD 7.53%
Dividend Est. 0.96 (0.39%)
P/FCF 33.16
EPS past 5Y 11.31%
ROI 6.30%
52W High -3.95%
Beta 0.85
Dividend TTM 1.05 (0.42%)
Quick Ratio 1.51
Sales past 5Y 8.35%
Gross Margin 58.35%
52W Low 36.61%
ATR (14) 4.79
Dividend Ex-Date Mar 27, 2024
Current Ratio 1.85
EPS Y/Y TTM -36.66%
Oper. Margin 21.32%
RSI (14) 55.04
Volatility 1.59% 1.77%
Employees 63000
Debt/Eq 0.36
Sales Y/Y TTM -15.25%
Profit Margin 16.78%
Recom 1.65
Target Price 274.37
Option/Short Yes / Yes
LT Debt/Eq 0.31
EPS Q/Q -25.02%
Payout 16.45%
Rel Volume 0.63
Prev Close 247.40
Sales Surprise 3.09%
EPS Surprise 11.84%
Sales Q/Q -19.13%
Earnings Apr 23 BMO
Avg Volume 2.58M
Price 248.76
SMA20 1.83%
SMA50 0.13%
SMA200 8.27%
Trades
Volume 1,632,113
Change 0.55%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-17-24 Upgrade
HSBC Securities
Hold → Buy
$280
Jan-24-24 Downgrade
Barclays
Overweight → Equal Weight
$240
Dec-18-23 Initiated
HSBC Securities
Hold
Dec-13-23 Resumed
Wolfe Research
Peer Perform
Dec-07-23 Downgrade
Goldman
Buy → Neutral
$215 → $205
Jul-19-23 Initiated
Raymond James
Outperform
$270
May-01-23 Initiated
SVB Securities
Outperform
$300
Apr-26-23 Downgrade
BofA Securities
Buy → Neutral
$310 → $250
Apr-18-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$275 → $285
Jan-05-23 Downgrade
Credit Suisse
Outperform → Neutral
$315 → $300
Dec-14-22 Initiated
Deutsche Bank
Buy
$310
Oct-24-22 Downgrade
The Benchmark Company
Buy → Hold
$325
Aug-25-22 Initiated
Credit Suisse
Outperform
$340
Aug-17-22 Resumed
Bernstein
Outperform
$330 → $340
Jul-20-22 Initiated
UBS
Buy
$297
Jun-01-22 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$299 → $310
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$265
Jan-11-22 Initiated
Bernstein
Outperform
$365
Oct-15-21 Resumed
Cowen
Outperform
$350
Sep-10-21 Reiterated
BofA Securities
Buy
$340 → $360
Show Previous Ratings
Today 04:45PM
04:15PM
May-06-24 02:50PM
May-05-24 08:19AM
May-03-24 09:06AM
08:00AM
Loading…
May-01-24 08:00AM
Apr-26-24 03:09PM
Apr-25-24 07:00PM
Apr-24-24 09:52AM
03:01AM
01:02AM
Apr-23-24 10:17PM
(Thomson Reuters StreetEvents) +7.21%
04:41PM
12:21PM
(The Wall Street Journal)
12:07PM
(Associated Press Finance)
11:39AM
Loading…
11:39AM
11:33AM
(Investor's Business Daily)
11:29AM
10:53AM
10:44AM
09:30AM
07:31AM
07:10AM
06:59AM
06:55AM
06:26AM
06:07AM
(Associated Press Finance)
06:00AM
05:37AM
Apr-19-24 09:52AM
04:27PM
Loading…
Apr-18-24 04:27PM
12:10PM
10:58AM
09:15AM
Apr-17-24 08:00AM
Apr-13-24 12:16PM
Apr-12-24 12:30PM
Apr-11-24 04:30PM
12:19PM
Apr-05-24 06:00PM
Apr-04-24 09:00AM
08:00AM
Apr-02-24 06:15PM
Mar-28-24 03:41AM
Mar-27-24 06:00PM
09:30AM
08:00AM
Mar-26-24 06:15PM
Mar-21-24 04:15PM
10:25AM
09:00AM
Mar-20-24 06:00PM
08:00AM
Mar-18-24 06:15PM
Mar-13-24 10:23AM
08:05AM
Mar-12-24 06:00PM
Mar-11-24 06:15PM
Mar-06-24 06:00AM
Mar-05-24 06:00PM
Mar-04-24 09:06AM
Mar-02-24 10:42AM
Mar-01-24 09:00AM
Feb-29-24 11:30AM
Feb-28-24 06:00PM
Feb-27-24 04:15PM
Feb-25-24 02:38PM
Feb-22-24 09:01PM
04:15PM
Feb-21-24 04:15PM
Feb-17-24 01:28PM
Feb-12-24 03:03PM
Feb-09-24 01:40AM
Feb-05-24 07:30AM
Feb-01-24 11:08AM
Jan-30-24 11:14PM
(Thomson Reuters StreetEvents)
01:26PM
11:44AM
11:08AM
09:30AM
07:10AM
06:34AM
06:17AM
(Associated Press Finance)
06:00AM
Jan-29-24 12:56PM
08:36AM
07:30AM
Jan-26-24 08:10AM
Jan-25-24 09:15AM
Jan-23-24 10:00AM
Jan-22-24 06:00PM
Jan-19-24 04:27AM
Jan-17-24 12:10PM
Jan-16-24 06:15PM
Jan-10-24 06:00PM
Jan-09-24 06:15PM
09:19AM
07:30AM
Jan-08-24 04:15PM
Jan-03-24 06:00PM
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SPOON ALAN G Director May 02 '24 Option Exercise 52.56 3,289 172,870 116,910 May 03 05:03 PM SPOON ALAN G Director May 02 '24 Sale 243.58 708 172,455 116,202 May 03 05:03 PM Weidemanis Joakim Executive Vice President Apr 25 '24 Option Exercise 58.48 22,433 1,311,882 112,845 Apr 26 05:00 PM Weidemanis Joakim Executive Vice President Apr 25 '24 Sale 250.46 22,433 5,618,569 90,412 Apr 26 05:00 PM Blair Rainer President & CEO Apr 24 '24 Option Exercise 59.91 38,170 2,286,870 154,165 Apr 25 05:00 PM Blair Rainer President & CEO Apr 24 '24 Sale 249.22 47,175 11,756,725 115,995 Apr 25 05:00 PM Ellis Brian W Senior Vice President - GC Apr 24 '24 Sale 250.01 4,000 1,000,040 29,830 Apr 25 05:00 PM Raskas Daniel SVP - Corporate Development Feb 26 '24 Option Exercise 58.48 23,757 1,389,309 61,859 Feb 27 05:01 PM Raskas Daniel SVP - Corporate Development Feb 26 '24 Sale 252.00 23,757 5,986,764 38,102 Feb 27 05:01 PM LOHR WALTER G Director Feb 15 '24 Option Exercise 52.56 3,289 172,870 17,418 Feb 16 05:01 PM LOHR WALTER G Director Feb 15 '24 Sale 251.15 3,289 826,032 14,129 Feb 16 05:01 PM Couchara Georgeann SVP, Human Resources Feb 13 '24 Option Exercise 70.71 2,622 185,414 6,022 Feb 14 05:00 PM Couchara Georgeann SVP, Human Resources Feb 13 '24 Sale 242.67 2,622 636,290 4,244 Feb 14 05:00 PM List Teri Director Feb 06 '24 Option Exercise 52.56 3,289 172,870 23,015 Feb 08 05:00 PM List Teri Director Feb 06 '24 Sale 248.32 3,289 816,724 19,726 Feb 08 05:00 PM Gutierrez-Ramos Jose-Carlos SVP, Chief Science Officer Aug 21 '23 Sale 250.54 590 147,819 6,939 Aug 22 05:00 PM Raskas Daniel SVP - Corporate Development Jul 28 '23 Option Exercise 56.70 11,213 635,777 49,501 Aug 01 05:03 PM Zerhouni Elias A. Director Jul 28 '23 Option Exercise 50.80 3,490 177,292 30,523 Aug 01 05:02 PM SCHWIETERS JOHN T Director Jul 28 '23 Option Exercise 50.80 3,490 177,292 22,583 Aug 01 05:02 PM FILLER LINDA Director Jul 28 '23 Option Exercise 59.17 2,922 172,895 41,074 Aug 01 05:00 PM Raskas Daniel SVP - Corporate Development Jul 28 '23 Sale 260.65 11,213 2,922,652 38,288 Aug 01 05:03 PM FILLER LINDA Director Jul 28 '23 Sale 260.25 10,190 2,651,978 38,152 Aug 01 05:00 PM Weidemanis Joakim Executive Vice President Jul 26 '23 Option Exercise 56.70 22,439 1,272,291 111,128 Jul 27 05:01 PM List Teri Director Jul 26 '23 Option Exercise 50.80 3,490 177,292 20,984 Jul 27 05:00 PM Weidemanis Joakim Executive Vice President Jul 26 '23 Sale 263.42 22,439 5,910,832 88,689 Jul 27 05:01 PM List Teri Director Jul 26 '23 Sale 263.30 3,490 918,917 17,494 Jul 27 05:00 PM Raskas Daniel SVP - Corporate Development May 31 '23 Option Exercise 57.90 19,847 1,149,141 58,520 Jun 01 05:00 PM Raskas Daniel SVP - Corporate Development May 31 '23 Sale 228.50 19,847 4,535,040 38,673 Jun 01 05:00 PM
Index S&P 500
P/E 30.44
EPS (ttm) 2.53
Insider Own 0.41%
Shs Outstand 350.70M
Perf Week 2.35%
Market Cap 27.12B
Forward P/E 18.48
EPS next Y 4.17
Insider Trans -16.36%
Shs Float 350.59M
Perf Month -8.53%
Income 899.60M
PEG 3.11
EPS next Q 0.92
Inst Own 95.40%
Short Float 0.92%
Perf Quarter -5.53%
Sales 6.13B
P/S 4.42
EPS this Y 11.00%
Inst Trans -8.27%
Short Ratio 1.96
Perf Half Y 16.82%
Book/sh 29.76
P/B 2.59
EPS next Y 9.52%
ROA 5.40%
Short Interest 3.23M
Perf Year 19.04%
Cash/sh 2.00
P/C 38.49
EPS next 5Y 9.80%
ROE 8.84%
52W Range 63.05 - 87.10
Perf YTD 4.63%
Dividend Est. 0.31 (0.41%)
P/FCF 20.45
EPS past 5Y -21.58%
ROI 6.16%
52W High -11.55%
Beta 1.14
Dividend TTM 0.30 (0.39%)
Quick Ratio 1.14
Sales past 5Y 0.13%
Gross Margin 59.55%
52W Low 22.19%
ATR (14) 1.44
Dividend Ex-Date May 31, 2024
Current Ratio 1.47
EPS Y/Y TTM 18.77%
Oper. Margin 18.48%
RSI (14) 37.45
Volatility 1.16% 1.80%
Employees 18000
Debt/Eq 0.39
Sales Y/Y TTM 3.71%
Profit Margin 14.68%
Recom 2.05
Target Price 88.74
Option/Short Yes / Yes
LT Debt/Eq 0.39
EPS Q/Q 19.63%
Payout 11.91%
Rel Volume 0.91
Prev Close 76.98
Sales Surprise -0.21%
EPS Surprise 4.09%
Sales Q/Q 4.37%
Earnings Apr 24 BMO
Avg Volume 1.65M
Price 77.04
SMA20 -2.60%
SMA50 -6.92%
SMA200 1.00%
Trades
Volume 1,499,994
Change 0.08%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-17-24 Downgrade
JP Morgan
Overweight → Neutral
$95 → $90
Mar-14-24 Initiated
Truist
Buy
$99
Jan-02-24 Downgrade
Vertical Research
Buy → Hold
Oct-26-23 Downgrade
BofA Securities
Buy → Neutral
$70
Oct-05-23 Initiated
Exane BNP Paribas
Outperform
$91
Aug-07-23 Initiated
Seaport Research Partners
Buy
$92
Mar-27-23 Upgrade
Vertical Research
Hold → Buy
$74
Oct-12-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$68 → $73
Mar-17-22 Upgrade
Argus
Hold → Buy
$68
Mar-14-22 Upgrade
Barclays
Equal Weight → Overweight
$75
Jan-03-22 Downgrade
Vertical Research
Buy → Hold
$82
Dec-17-21 Initiated
Mizuho
Neutral
$82
Nov-23-21 Initiated
Loop Capital
Buy
$90
Oct-08-21 Initiated
Wells Fargo
Equal Weight
$72
Jul-12-21 Upgrade
Wolfe Research
Peer Perform → Outperform
May-20-21 Upgrade
JP Morgan
Neutral → Overweight
$70 → $80
Feb-17-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$75
Dec-08-20 Downgrade
Wolfe Research
Outperform → Peer Perform
$71 → $78
Dec-04-20 Initiated
UBS
Buy
$83
Nov-30-20 Downgrade
Barclays
Overweight → Equal Weight
$72
Show Previous Ratings
May-06-24 02:50PM
May-01-24 04:15PM
12:00PM
Apr-26-24 08:52AM
Apr-25-24 01:01PM
01:04AM
Loading…
01:04AM
Apr-24-24 06:38PM
(Morningstar Research) -5.76%
11:52AM
09:30AM
08:51AM
08:40AM
08:10AM
07:39AM
(Associated Press Finance)
07:30AM
Apr-19-24 09:15AM
09:15AM
Loading…
09:15AM
Apr-18-24 09:35AM
Apr-17-24 10:01AM
Apr-04-24 04:15PM
Mar-28-24 04:15PM
03:41AM
Mar-20-24 11:40AM
Mar-19-24 07:00AM
Mar-14-24 09:40AM
Mar-13-24 10:53AM
Mar-12-24 04:15PM
Mar-06-24 04:15PM
Mar-04-24 09:06AM
Mar-01-24 11:30AM
Feb-29-24 09:40AM
12:04AM
Loading…
Feb-28-24 12:04AM
Feb-09-24 04:15PM
04:15PM
Feb-08-24 05:27PM
Feb-03-24 12:01PM
Feb-02-24 09:55AM
Feb-01-24 06:54PM
(Morningstar Research) +5.18%
11:17AM
07:22AM
03:20AM
(Thomson Reuters StreetEvents)
Jan-31-24 06:14PM
09:30AM
08:40AM
07:50AM
(Associated Press Finance)
07:30AM
Jan-26-24 09:15AM
Jan-24-24 10:00AM
Jan-23-24 04:30PM
04:30PM
Jan-16-24 11:00AM
Jan-04-24 09:03AM
Jan-03-24 07:02AM
Dec-21-23 04:15PM
Dec-05-23 08:00AM
Nov-24-23 11:31AM
Nov-02-23 04:15PM
Oct-31-23 04:15PM
Oct-27-23 02:29PM
Oct-26-23 11:09AM
09:56AM
08:44AM
05:01AM
(Thomson Reuters StreetEvents)
Oct-25-23 10:17AM
09:48AM
07:51AM
(Associated Press Finance)
07:30AM
Oct-23-23 06:53AM
06:51AM
06:00AM
Oct-19-23 09:00AM
Oct-18-23 10:01AM
Oct-03-23 02:37PM
Sep-29-23 05:30PM
Sep-19-23 10:30AM
Sep-12-23 11:00AM
Aug-31-23 12:16PM
Aug-30-23 04:15PM
12:41PM
Aug-29-23 01:02PM
Aug-24-23 05:27PM
Aug-18-23 11:39AM
Aug-17-23 05:15PM
Aug-03-23 03:52PM
Jul-27-23 07:30AM
07:30AM
06:19AM
Jul-26-23 08:05PM
07:41AM
07:30AM
Jul-20-23 02:30PM
Jul-06-23 01:13PM
Jun-29-23 04:15PM
Jun-28-23 10:24AM
Jun-27-23 10:07AM
07:37AM
07:22AM
Jun-22-23 08:00AM
Jun-05-23 04:15PM
01:00PM
Jun-02-23 01:38PM
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walker Stacey A. SVP - Human Resources Feb 29 '24 Sale 85.11 842 71,663 35,716 Mar 01 05:23 PM Walker Stacey A. SVP - Human Resources Feb 28 '24 Option Exercise 33.36 2,331 77,762 45,664 Mar 01 05:23 PM McLaughlin Charles E SVP - Chief Financial Officer Feb 28 '24 Sale 86.28 40,837 3,523,416 61,855 Mar 01 05:23 PM Walker Stacey A. SVP - Human Resources Feb 28 '24 Sale 86.50 9,106 787,669 36,558 Mar 01 05:23 PM Underwood Peter C SVP - General Counsel Feb 28 '24 Sale 86.39 5,000 431,950 47,138 Mar 01 05:23 PM Schwarz Jonathan L SVP - Corporate Development Feb 23 '24 Option Exercise 31.07 11,315 351,557 67,116 Feb 27 06:14 PM Newcombe Tamara S. President & CEO of AHS and PT Feb 16 '24 Sale 85.00 5,000 425,000 55,017 Feb 20 08:32 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 09 '24 Option Exercise 36.09 8,994 324,601 29,558 Feb 12 06:55 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 09 '24 Option Exercise 35.61 6,088 216,788 12,072 Feb 12 06:55 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 09 '24 Sale 82.17 8,994 739,037 20,564 Feb 12 06:55 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 09 '24 Sale 82.26 6,088 500,799 5,984 Feb 12 06:55 PM LICO JAMES A President and CEO Feb 06 '24 Option Exercise 30.61 106,525 3,260,982 546,473 Feb 06 06:40 PM LICO JAMES A President and CEO Feb 06 '24 Sale 81.50 106,525 8,681,347 439,948 Feb 06 06:40 PM LICO JAMES A President and CEO Feb 02 '24 Option Exercise 31.07 100,000 3,107,000 539,948 Feb 06 06:40 PM LICO JAMES A President and CEO Feb 02 '24 Sale 82.30 100,000 8,230,000 439,948 Feb 06 06:40 PM LICO JAMES A President and CEO Jul 28 '23 Option Exercise 27.26 185,540 5,057,820 485,797 Jul 31 05:47 PM Murphy Patrick K President & CEO of AHS Jul 28 '23 Option Exercise 35.38 21,793 771,036 82,509 Jul 31 05:49 PM McLaughlin Charles E SVP - Chief Financial Officer Jul 28 '23 Option Exercise 27.26 16,911 460,994 118,230 Jul 31 05:51 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 '23 Option Exercise 29.63 4,436 131,436 10,549 Jul 31 05:54 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 '23 Option Exercise 29.32 3,869 113,434 26,207 Jul 31 05:54 PM Murphy Patrick K President & CEO of AHS Jul 28 '23 Sale 76.50 21,793 1,667,164 60,716 Jul 31 05:49 PM McLaughlin Charles E SVP - Chief Financial Officer Jul 28 '23 Sale 76.66 16,911 1,296,397 101,319 Jul 31 05:51 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 '23 Sale 76.85 4,700 361,195 21,507 Jul 31 05:54 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 '23 Sale 76.84 4,436 340,862 6,113 Jul 31 05:54 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite